Relief Therapeutics Holding AG
OTC: RLFTD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jack Weinstein
- Employees
- 69
- Headquarters
- Geneva, Switzerland
- IPO year
- 2021
- Market cap
- $44.9M
- Website
- https://www.relieftherapeutics.com
Loading RLFTD…
Loading profile data…Frequently asked questions about RLFTD
What does Relief Therapeutics Holding AG (RLFTD) do?
Relief Therapeutics Holding AG operates as a biopharmaceutical firm, dedicated to providing vital therapeutic relief to patients suffering from severe diseases for which current medical solutions are insufficient. The company's reach extends across Switzerland, the broader European continent, North America, and various international markets. Its...
Where does RLFTD trade?
Relief Therapeutics Holding AG (RLFTD) trades on the Other OTC.
What sector is RLFTD in?
Relief Therapeutics Holding AG (RLFTD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Relief Therapeutics Holding AG?
Jack Weinstein is the chief executive officer of Relief Therapeutics Holding AG (RLFTD).
Where is Relief Therapeutics Holding AG headquartered?
Relief Therapeutics Holding AG is headquartered in Switzerland.
Does RLFTD pay a dividend?
Relief Therapeutics Holding AG (RLFTD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RLFTD go public?
Relief Therapeutics Holding AG (RLFTD) completed its initial public offering in 2021.